Case Control Study
Copyright ©The Author(s) 2016.
World J Radiol. Apr 28, 2016; 8(4): 378-389
Published online Apr 28, 2016. doi: 10.4329/wjr.v8.i4.378
Table 4 Patient demographics, histological diagnosis, location of tumor, blood loss, transfusion requirement and surgical time of study group and control group for the entire study population
S.NoStudy group (embolisation group), n = 26
Control group (non-embolisation group), n = 28
Age/sexDiagnosisSiteEmbolising agentBlood loss (mL)Transfusion (mL)Surgical time (min)Age/sexDiagnosisSiteBlood loss (mL)Transfusion (mL)Surgical time (min)
152 MGCTLLPVA + GEL FOAM2900140023010 FABCLL1450750170
230 MGCTLLPVA + GEL FOAM174070023146 FGCTLL13001400240
318 MOBSPINEPVA + GEL FOAM165070024058 MGCTLL16001450230
417 MABCSPINEPVA + GEL FOAM160070035520 FABCUL18001400195
542 MGCTLLPVA + GEL FOAM150070034028 FOBSPINE25001750195
614 FABCSPINEPVA + GEL FOAM120070023031 MGCTLL12501050220
734 MCSILIUMGEL FOAM1900140045021 MGCTLL25001050145
839 FGCTLLPVA + GEL FOAM160070024034 MGCTSPINE25001400295
945 FGCTLLPVA + GEL FOAM130035018034 FGCTLL18001400150
1031 MGCTLLPVA250011560 FGCTLL1200700150
1120 FGCTULPVA + GEL FOAM130070025020 MGCTLL60008400450
1225 FGCTSPINEPVA130070023028 MOBSPINE1300700230
1348 MGCTSACRUMPVA140070024030 MGCTLL20002100350
1415 MGCTULPVA + GEL FOAM50035017045 FGCTLL15001400225
1532 FGCTLLPVA + GEL FOAM160070026022 MGCTLL43002100315
1630 FGCTULPVA350013540 FGCTLL18001400245
1728 FGCTLLPVA + GEL FOAM140070024024 FGCTLL800700290
1832 MGCTLLPVA40035019016 MCBLL14001050185
1945 FGCTULPVA2100105024517 MGCTUL1800700180
2020 MGCTLLPVA600012522 FGCTLL15001050260
2120 FGCTLLPVA80035014534 MGCTUL900700245
2282 MGCTLLPVA90035015529 FGCTLL15001400270
2315 MCBLLPVA75035013526 MGCTLL16001050290
2422 MGCTULPVA+GEL FOAM1800140023027 FGCTLL26002100335
2552 MCSULPVA500025018 MGCTLL34502450330
2642 FGCTULPVA300014023 FGCTUL26002050285
2721 FGCTLL21001400245
2824 MGCTLL19001400290